Rosemary A Crane Insider Trading $EDGE PDS Biotechnology Corp
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Rosemary A Crane.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Rosemary A Crane. Rosemary A Crane is Director in TEVA PHARMACEUTICAL INDUSTRIES LTD ($TEVA) and Director in Targanta Therapeutics Corp. ($TARG) and Director in Edge Therapeutics, Inc. ($EDGE) and Director in Catalent, Inc. ($CTLT).
Rosemary A Crane in PDS Biotechnology Corp
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Rosemary A Crane: Director
Holdings: 10,000 shares
Current Value: $95,500
Latest Transaction: Mar 18 2019
$EDGE Market Capitalization: $272.98M
$EDGE Previous Close: $9.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Rosemary A Crane in PDS Biotechnology Corp
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CTLT, EDGE, TARG, TEVA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | Crane Rosemary A | Director | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | Crane Rosemary A | Director | Buy | M | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Aug 15 2018 | EDGE | Edge Therapeutics, ... | Crane Rosemary A | Director | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
| Jun 20 2018 | EDGE | Edge Therapeutics, ... | Crane Rosemary A | Director | Option Exercise | A | 1.10 | 20,000 | 22,000 | 20,000 | |
| Sep 20 2017 | EDGE | Edge Therapeutics, ... | Crane Rosemary A | Director | Option Exercise | A | 9.43 | 30,000 | 282,900 | 30,000 |
Page: 1